Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 1
1952 5
1953 3
1955 1
1956 3
1957 5
1958 1
1960 1
1961 1
1962 2
1963 1
1964 3
1965 4
1967 3
1968 1
1970 2
1971 1
1974 1
1975 1
1976 3
1977 3
1978 2
1979 1
1980 3
1981 1
1982 1
1983 3
1984 7
1985 1
1986 2
1987 5
1988 3
1989 4
1990 4
1991 6
1992 7
1993 2
1994 8
1995 2
1996 10
1997 7
1998 15
1999 16
2000 14
2001 17
2002 10
2003 16
2004 5
2005 17
2006 19
2007 19
2008 28
2009 19
2010 25
2011 21
2012 23
2013 26
2014 27
2015 34
2016 28
2017 26
2018 28
2019 23
2020 25
2021 42
2022 38
2023 42
2024 40
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

721 results

Results by year

Filters applied: . Clear all
Page 1
The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, Washington MK, Rosero A, Garcia LS, Realpe JL, Cifuentes SP, Morgan DR, Peek RM Jr, Correa P, Wilson KT. Piazuelo MB, et al. Among authors: bravo jc. Gastroenterology. 2021 Mar;160(4):1106-1117.e3. doi: 10.1053/j.gastro.2020.11.017. Epub 2020 Nov 18. Gastroenterology. 2021. PMID: 33220252 Free PMC article. Clinical Trial.
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease.
Ayalon G, Lee SH, Adolfsson O, Foo-Atkins C, Atwal JK, Blendstrup M, Booler H, Bravo J, Brendza R, Brunstein F, Chan R, Chandra P, Couch JA, Datwani A, Demeule B, DiCara D, Erickson R, Ernst JA, Foreman O, He D, Hötzel I, Keeley M, Kwok MCM, Lafrance-Vanasse J, Lin H, Lu Y, Luk W, Manser P, Muhs A, Ngu H, Pfeifer A, Pihlgren M, Rao GK, Scearce-Levie K, Schauer SP, Smith WB, Solanoy H, Teng E, Wildsmith KR, Bumbaca Yadav D, Ying Y, Fuji RN, Kerchner GA. Ayalon G, et al. Among authors: bravo j. Sci Transl Med. 2021 May 12;13(593):eabb2639. doi: 10.1126/scitranslmed.abb2639. Sci Transl Med. 2021. PMID: 33980574 Clinical Trial.
Type III-B CRISPR-Cas cascade of proteolytic cleavages.
Steens JA, Bravo JPK, Salazar CRP, Yildiz C, Amieiro AM, Köstlbacher S, Prinsen SHP, Andres AS, Patinios C, Bardis A, Barendregt A, Scheltema RA, Ettema TJG, van der Oost J, Taylor DW, Staals RHJ. Steens JA, et al. Among authors: bravo jpk. Science. 2024 Feb 2;383(6682):512-519. doi: 10.1126/science.adk0378. Epub 2024 Feb 1. Science. 2024. PMID: 38301007 Free PMC article.
Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9.
Hibshman GN, Bravo JPK, Hooper MM, Dangerfield TL, Zhang H, Finkelstein IJ, Johnson KA, Taylor DW. Hibshman GN, et al. Among authors: bravo jpk. Nat Commun. 2024 Apr 30;15(1):3663. doi: 10.1038/s41467-024-47830-3. Nat Commun. 2024. PMID: 38688943 Free PMC article.
Modeling interactions in ambient intelligence.
Castro LA, Bravo J. Castro LA, et al. Among authors: bravo j. Pers Ubiquitous Comput. 2022;26(6):1333-1335. doi: 10.1007/s00779-021-01565-w. Epub 2021 Apr 16. Pers Ubiquitous Comput. 2022. PMID: 33880116 Free PMC article. No abstract available.
Anti-plasmid immunity: a key to pathogen success?
Bravo JPK. Bravo JPK. Future Microbiol. 2024;19(15):1269-1272. doi: 10.1080/17460913.2024.2389720. Epub 2024 Sep 4. Future Microbiol. 2024. PMID: 39230568 No abstract available.
721 results